Safety and Efficacy of Treatment with Dupilumab for up to 2 Years in Infants and Young Children with Atopic Dermatitis

20260 citationsJournal Articlehybrid Open Access

Authors

ClinicalTrials.gov Identifier: NCT02612454.

Good health and well-being

Published in: American Journal of Clinical Dermatology

Field-Weighted Citation Impact: 0.00